Research priorities for intracranial atherosclerotic diseases

Journal of Neuroimaging

Volumn 19, Issue SUPPL. 1, 2009, Pages

  Qureshi, Adnan I ^a   Taylor, Robert A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Intracranial atherosclerosis; Intracranial stenosis; Plaque morphology; Plaque regression

Indexed keywords

ANGIOGENIC FACTOR; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN;

ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; CLINICAL TRIAL; DISEASE MARKER; DISEASE SEVERITY; DOG; DRUG MEGADOSE; EXPERIMENTAL MODEL; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; RESEARCH PRIORITY; REVIEW; STENOSIS; SWINE; THERMOGRAPHY;

ANIMALS; BRAIN; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS;

EID: 70350475834     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00422.x     Document Type: Review

References (52)

1. Ito T, Shiomi M. Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits. Atherosclerosis 2001 156 : 57 66.
2. Kong J, Tamaki N, Asada M. Early lesions of cerebral atherosclerosis from induced hypertension in Watanabe heritable hyperlipidemic rabbits. Kobe J Med Sci 2000 46 : 87 101.
3. Gallagher PJ, Nanjee MN, Richards T, et al. Biochemical and pathological features of a modified strain of Watanabe heritable hyperlipidaemic rabbits. Atherosclerosis 1988 71 : 173 183.
4. Kato H, Tokunaga O, Watanabe T, et al. Experimental cerebral atherosclerosis in the rabbit. Scanning electron microscopic study of the initial lesion site. Pathol Res Pract 1991 187 : 797 805.
5. Kurozumi T, Imamura T, Tanaka K, Yae Y, Koga S. Permeation and deposition of fibrinogen and low-density lipoprotein in the aorta and cerebral artery of rabbits-immuno-electron microscopic study. Br J Exp Pathol 1984 65 : 355 364.
6. Sadoshima S, Tanaka K. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 1979 34 : 93 103.
7. Nakamura M, Imaizumi K, Kikuchi Y, et al. Cerebral atherosclerosis in Japanese. Part 4: relationship between lipid content and macroscopic severity of atherosclerosis. Stroke 1976 7 : 591 594. (Pubitemid 8003018)
8. Kurozumi T, Tanaka K, Yae Y. Hypertension-induced cerebral atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 1978 30 : 137 145.
9. Favalli L, Lanza E, Rozza Dionigi A, et al. Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit. Drugs Exp Clin Res 1985 11 : 845 850.
10. Hollander W, Prusty S, Kemper T, et al. The effects of hypertension on cerebral atherosclerosis in the cynomolgus monkey. Stroke 1993 24 : 1218 1226 discussion 26-7.
11. Prusty S, Kemper T, Moss MB, et al. Occurrence of stroke in a nonhuman primate model of cerebrovascular disease. Stroke 1988 19 : 84 90.
12. Suzuki M, Yamamoto D, Suzuki T, et al. High fat and high fructose diet induced intracranial atherosclerosis and enhanced vasoconstrictor responses in non-human primate. Life Sci 2006 80 : 200 204.
13. Fincham JE, Gouws E, Woodroof CW, et al. Atherosclerosis. Chronic effects of fish oil and a therapeutic diet in nonhuman primates. Arterioscler Thromb 1991 11 : 719 732.
14. Shimamoto T. Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders. Jpn Heart J 1975 16 : 76 97.
15. Baptista AG. Studies on the arteries of the brain. I. Etiologic factors in cerebral atherosclerosis. Angiology 1962 13 : 367 371.
16. Suzuki M. Experimental cerebral atherosclerosis in the dog. I. A morphologic study. Am J Pathol 1972 67 : 387 402.
17. Belza J, Rubinstein LJ, Maier N, et al. Experimental cerebral atherosclerosis in dogs. Ann N Y Acad Sci 1968 149 : 895 906.
18. Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004 100 : 688 694.
19. Imai H, Thomas WA. Cerebral atherosclerosis in swine: role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp Mol Pathol 1968 8 : 330 357.
20. Nystroem HM. Electron microscopic studies on cholesterol-induced cerebral atherosclerosis in cockerels. Acta Neuropathol 1963 3 : 48 56.
21. Aoki S, Shirouzu I, Sasaki Y, et al. Enhancement of the intracranial arterial wall at MR imaging: relationship to cerebral atherosclerosis. Radiology 1995 194 : 477 481.
22. Janardhan V, Qureshi AI. Advances in interventional neuroimaging. Neurotherapeutics 2007 4 : 414 419.
23. Ravalli S, LiMandri G, Di Tullio MR, et al. Intravascular ultrasound imaging of human cerebral arteries. J Neuroimaging 1996 6 : 71 75.
24. Wehman JC, Holmes DR, Jr., Hanel RA, et al. Intravascular ultrasound for intracranial angioplasty and stent placement: technical case report. Neurosurgery 2006 59 : ONSE481 3 discussion ONSE3.
25. Diethrich EB, Pauliina Margolis M, Reid DB, et al. Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther 2007 14 : 676 686.
26. Campani R, Bottinelli O, Calliada F, et al. The latest in ultrasound: three-dimensional imaging. Part II. Eur J Radiol 1998 27 (Suppl 2 S183 S187.
27. Goertz DE, Frijlink ME, Tempel D, et al. Contrast harmonic intravascular ultrasound: a feasibility study for vasa vasorum imaging. Invest Radiol 2006 41 : 631 638.
28. Lindner JR. Evolving applications for contrast ultrasound. Am J Cardiol 2002 90 : 72J 80J.
29. Vavuranakis M, Kakadiaris IA, O'Malley SM, et al. Images in cardiovascular medicine. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. Circulation 2005 112 : e1 e2.
30. Wainstein M, Costa M, Ribeiro J, et al. Vulnerable plaque detection by temperature heterogeneity measured with a guidewire system: clinical, intravascular ultrasound and histopathologic correlates. J Invasive Cardiol 2007 19 : 49 54.
31. Shikhaliev PM, Xu T, Ducote JL, et al. Positron autoradiography for intravascular imaging: feasibility evaluation. Phys Med Biol 2006 51 : 963 979.
32. Larose E, Yeghiazarians Y, Libby P, et al. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation 2005 112 : 2324 2331.
33. Hamzei F, Knab R, Weiller C, et al. The influence of extra- and intracranial artery disease on the BOLD signal in FMRI. Neuroimage 2003 20 : 1393 1399.
34. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006 113 : 2826 2834. (Pubitemid 44305295)
35. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006 295 : 1556 1565.
36. Grondin CM, Dyrda I, Pasternac A, et al. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation 1974 49 : 703 708.
37. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic-histologic correlative analysis in 28 patients. Circulation 1981 63 : 1056 1064.
38. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984 310 : 819 824.
39. De Scheerder I, De Man F, Herregods MC, et al. Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries. Am Heart J 1994 127 : 243 251.
40. Berry C, L'Allier PL, Gregoire J, et al. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007 115 : 1851 1857.
41. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growthfactor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998 115 : 168 176 discussion 76-7.
42. Stewart DJ, Hilton JD, Arnold JM, et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther 2006 13 : 1503 1511.
43. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999 77 : 527 543. (Pubitemid 29426311)
44. Gyongyosi M, Khorsand A, Zamini S, et al. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 2005 112 : I157 1165.
45. Kastrup J, Jorgensen E, Ruck A, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 2005 45 : 982 988.
46. Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002 105 : 1291 1297.
47. Wright MJ, Wightman LM, Latchman DS, et al. In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther 2001 8 : 1833 1839.
48. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 352 : 1305 1316.
49. Suri MF, Divani AA, Hoffmann KR, Qureshi AI. Intracranial atherosclerotic disease: medical, biomechanical, imaging, and flow dynamics perspective. J Neuroimaging 2008.
50. Simons MA, Kruger RA, Power RL. Cross-sectional area measurements by digital subtraction videodensitometry. Invest Radiol 1986 21 : 637 644.
51. Divani AA, Qureshi AI, Hoffman KR, et al. Comparison of asymmetry in cerebral blood flow between brain hemispheres using digital subtraction angiography. J Neuroimaging 2006 16 : 139 145.
52. Ganguly A, Rudin S, Bednarek DR, et al. Micro-angiography for neuro-vascular imaging. II. Cascade model analysis. Med Phys 2003 30 : 3029 3039. (Pubitemid 37444313)